Dynex Capital Inc
DX NYSE Real Estate Investment Trusts Financials FY2016βFY2025
What Dynex Capital Inc does
No business description yet.
- Legal name
- DYNEX CAPITAL INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0000826675-26-000017
0000826675
Revenue and margins
Dynex Capital Inc had $114M of revenue in fiscal 2025, up 1,845.8% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 15.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Dynex Capital Inc returned $247M to shareholders in fiscal 2025. The diluted share count rose 75.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Dynex Capital Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $366M | $332M | $120M | $377M | $531M |
| Total assets | $3.6B | $3.6B | $6.4B | $8.2B | $17.3B |
| Total liabilities | $2.9B | $2.7B | $5.5B | $7.0B | $14.9B |
| Shareholders' equity | $771M | $901M | $871M | $1.2B | $2.5B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β4.9% | β5.1% | β4.8% | β7.1% | 0.1% | β1.3% | 0.5% | β1.4% | 1.4% | 1.6% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $66.7M | $58.3M | $50.5M | $56.1M | $63.9M | $54.4M | $43.1M | β$7.9M | $5.9M | $114M |
| Net interest income | $66.7M | $58.3M | $50.5M | $56.1M | $63.9M | $54.4M | $43.1M | β$7.9M | $5.9M | $114M |
| Provision for credit losses | $0.1M | $0.1M | $0.1M | $0.1M | β | β | β | β | β | β |
| Interest expense | $25.2M | $36.2M | $59.6M | $114M | $32.6M | $5.7M | $43.6M | $215M | β | β |
| Net income | $43.1M | $33.9M | $7.0M | β$153M | $178M | $102M | $143M | β$6.1M | $114M | $319M |
| Net income to common | $33.9M | $23.1M | β$4.8M | β$166M | $160M | $90.9M | $135M | β$13.8M | $106M | $309M |
| Diluted EPS | $0.69 | $1.37 | β$0.25 | β$7.01 | $6.93 | $2.78 | $3.17 | β$0.25 | $1.49 | $2.47 |
| Diluted shares | 0.05B | 0.02B | 0.02B | 0.02B | 0.02B | 0.03B | 0.04B | 0.05B | 0.07B | 0.13B |
| Cash flow | ||||||||||
| Cash from operations | $211M | $204M | $181M | $175M | $174M | $147M | $126M | $62.2M | $14.4M | $121M |
| Stock-based compensation | $2.7M | $2.0M | $1.2M | $1.2M | $1.8M | $2.5M | $4.4M | $4.8M | $7.2M | $12.6M |
| Share buybacks | $0.3M | $0.0M | $0.0M | $25.0M | $0.4M | $0.0M | $0.0M | β | β | β |
| Dividends paid | $51.9M | $47.5M | $52.8M | $68.0M | $52.4M | $58.9M | $72.4M | $93.0M | $118M | $247M |
| Dividends and buybacks | $52.2M | $47.5M | $52.8M | $93.1M | $52.8M | $58.9M | $72.4M | $93.0M | $118M | $247M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $74.1M | $40.9M | $34.6M | $62.6M | $296M | $366M | $332M | $120M | $377M | $531M |
| Total debt | $6.4M | β | β | β | β | β | β | β | β | β |
| Loans, net | $19.0M | β | β | β | β | β | β | β | β | β |
| Total assets | $3.4B | $3.3B | $3.9B | $5.4B | $3.1B | $3.6B | $3.6B | $6.4B | $8.2B | $17.3B |
| Total liabilities | $2.9B | $2.7B | $3.4B | $4.8B | $2.5B | $2.9B | $2.7B | $5.5B | $7.0B | $14.9B |
| Preferred stock | $110M | β | β | β | β | β | β | β | β | β |
| Shareholders' equity | $467M | $557M | $527M | $583M | $633M | $771M | $901M | $871M | $1.2B | $2.5B |
| Margins | ||||||||||
| Net margin | 64.6% | 58.1% | 13.9% | β272.3% | 278.0% | 188.0% | 332.3% | 77.3% | 1,938.0% | 279.0% |
| Net interest share of revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Returns | ||||||||||
| Return on equity | 9.2% | 6.6% | 1.3% | β27.5% | 29.2% | 14.6% | 17.1% | β0.7% | 11.1% | 17.5% |
| Return on assets | 1.3% | 1.0% | 0.2% | β3.3% | 4.2% | 3.0% | 4.0% | β0.1% | 1.6% | 2.5% |
| Return on tangible equity | 7.3% | 4.1% | β0.9% | β28.4% | 25.3% | 11.8% | 15.0% | β1.6% | 9.0% | 12.5% |
| Growth | ||||||||||
| Revenue growth | β | β12.5% | β13.5% | 11.1% | 13.9% | β14.8% | β20.8% | β118.4% | β | 1,845.8% |
| Net income growth | β | β21.4% | β79.3% | β2,273.8% | β | β42.4% | 40.0% | β104.3% | β | 180.1% |
| EPS growth | β | 98.6% | β118.2% | β | β | β59.9% | 14.0% | β107.9% | β | 65.8% |
| Share count change | β | β65.8% | 14.5% | 22.8% | β2.2% | 41.8% | 30.5% | 28.2% | 30.0% | 75.5% |
| Financial health | ||||||||||
| Debt / equity | 0.0x | β | β | β | β | β | β | β | β | β |
| Provision / loans | 0.7% | β | β | β | β | β | β | β | β | β |
| Capital allocation | ||||||||||
| Stock comp / revenue | 4.1% | 3.4% | 2.4% | 2.1% | 2.9% | 4.6% | 10.3% | β60.9% | 123.1% | 11.0% |
| Quality scores | ||||||||||
| Accruals ratio | β4.9% | β5.1% | β4.8% | β7.1% | 0.1% | β1.3% | 0.5% | β1.4% | 1.4% | 1.6% |
Source: SEC EDGAR XBRL filings (CIK 0000826675). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.